Charles Schwab’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Charles Schwab’s Portfolio ASPX Stock Details ASPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-43,269	Closed	-$4.34M	–	3208
2015 Q1	$4.34M	Buy	43,269 +19,269	+80%	+$1.28M	0.01%	1601
2014 Q4	$1.26M	Buy	24,000 +854	+4%	+$25.1K	﹤0.01%	2246
2014 Q3	$595K	Buy	23,146 +5,230	+29%	+$111K	﹤0.01%	2522
2014 Q2	$399K	Buy	+17,916	New	+$392K	﹤0.01%	2731

Charles Schwab's ASPX Position: Q2 2015 in Review

Charles Schwab sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 43,269 shares — an estimated $4.34M sold.

Charles Schwab first reported a position in ASPX in Q2 2014 and held it in 4 quarters. The position peaked at $4.34M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

Charles Schwab reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Charles Schwab sold 43,269 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $4.34M.
Charles Schwab first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 4 quarters.
Charles Schwab's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $4.34M in Q1 2015.
0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Charles Schwab's 13F filing for Q2 2015, filed 14 Aug 2015.